Policy Notices

• Notice of Extension PA-17-008
  (NOT-HS-21-009)
  Agency for Healthcare Research and Quality
  

• Notice of Changes in the Review Criteria for Applications Submitted for NIH Support for Scientific Conferences (R13 and U13)
  (NOT-OD-21-055)
  National Institutes of Health
  

• Policy on Protecting Life in Global Health Assistance is Revoked
  (NOT-OD-21-063)
  National Institutes of Health
  

General Notices

• Findings of Research Misconduct
  (NOT-OD-21-061)
  National Institutes of Health
  

• Notice of Pre-Application Webinar for RFA-TR-21-008, Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional)
  (NOT-TR-21-021)
  National Center for Advancing Translational Sciences
  

• Request for Information (RFI): Inviting Comments on the NCCIH Strategic Plan for Fiscal Years 2021-2025
  (NOT-AT-21-005)
  National Center for Complementary and Integrative Health
  

Notice of Changes to Funding Opportunities

• Notice of Change to Eligibility of Foreign Components and Requirement for Letter of Support for PAR-21-109, "Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
  (NOT-AG-21-017)
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

• Notice of Change to Key Dates for PA-21-110, "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)"
  (NOT-DA-21-040)
  National Institute on Drug Abuse
  

• Notice to Extend the Application Due Date for RFA-FD-21-014 - "Development of Methods to Evaluate the Impact of Design Differences to the User Interface of Generic Drug-Device Combination Products in Comparison to their Reference Listed Drugs (U01)"
  (NOT-FD-21-007)
  Food and Drug Administration
  

• Notice to correct email address for submission of Letter of Intent - RFA-FD-21-016 -Development of Advanced Analytical Methods for the Characterization of Iron Carbohydrate Complex - Ferric Derisomaltose (U01)
  (NOT-FD-21-008)
  Food and Drug Administration
  

• Notice to Extend the Application Due Date for RFA-FD-21-013 - Physiologically-based pharmacokinetic (PBPK) models to aid the development of generic dermatological products (U01) Clinical Trials Optional
  (NOT-FD-21-009)
  Food and Drug Administration
  

• Early Expiration of PAR-20-091 Revision Applications - FSMA Human Foods Preventive Controls Implementation Expansion Supplement to RFA-FD-18-001 (U18 Clinical Trials Not Allowed)
  (NOT-FD-21-010)
  Food and Drug Administration
  

• Notice of Early Expiration of NOT-MD-20-011 Notice of Special Interest: Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)
  (NOT-MD-21-013)
  National Institute on Minority Health and Health Disparities
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Specialized Alcohol Research Centers (P50 Clinical Trial Optional)
  (NOT-AA-21-004)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional)
  (NOT-AA-21-005)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed)
  (NOT-AI-21-031)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Autism Centers of Excellence: Networks (R01 Clinical Trial Optional)
  (NOT-HD-21-006)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Autism Centers of Excellence: Centers (P50 Clinical Trial Optional)
  (NOT-HD-21-007)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  

• Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Optional)
  (NOT-OD-21-065)
  National Institutes of Health
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Research
  (NOT-AI-21-011)
  National Institute of Allergy and Infectious Diseases
  National Institute of Mental Health
  

• Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders
  (NOT-DA-21-019)
  National Institute on Drug Abuse
  

• Notice of Special Interest: Availability of Administrative Supplements to INBRE Awards to Fund Research Collaborations
  (NOT-GM-21-016)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination
  (NOT-NS-21-014)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  

• Notice of Special Interest (NOSI): Availability of Administrative Supplements for Submission of Tissue Chip Data to the Microphysiology Systems Database (MPS-Db)
  (NOT-TR-21-019)
  National Center for Advancing Translational Sciences
  

Funding Opportunities

• NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
  (PA-21-151)
  National Institutes of Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Library of Medicine
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): January 07, 2024
  
  

• Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
  (PA-21-164)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Standard dates apply. All applications are due by 5:00 PM local time of the applicant organization Applicants are encouraged to apply early to allow adequate time to for them to make, by the due date, corrections to any errors found in the application during the submission process.
  
  

• NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional)
  (PAR-20-319)
  National Eye Institute
  Application Receipt Date(s): April 13, 2021; February 9, 2022; February 9, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• NIDCR Predoctoral to Postdoctoral Transition Award for a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed)
  (PAR-21-060)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply
  
  

• Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
  (PAR-21-115)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): January 07, 2024
  
  

• Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
  (PAR-21-125)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of General Medical Sciences
  Application Receipt Date(s): June 15, 2021
  
  

• High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
  (PAR-21-126)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of General Medical Sciences
  Application Receipt Date(s): June 15, 2021
  
  

• Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
  (PAR-21-127)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of General Medical Sciences
  Application Receipt Date(s): June 15, 2021
  
  

• Underground Mine Evacuation Technologies and Human Factors Research (U60)
  (PAR-21-165)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): April 12, 2021; February 10, 2022
  
  

• Human Immunology Project Consortium (U19 Clinical Trial Optional)
  (RFA-AI-20-079)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 4, 2021
  
  

• Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed)
  (RFA-AI-20-080)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 04, 2021
  
  

• Basic Research to Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV) (R01 Clinical Trial Not Allowed)
  (RFA-AI-21-006)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): July 13, 2021
  
  

• Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)
  (RFA-RM-21-011)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): June 18, 2021